首页> 外文期刊>The pharmaceutical journal >Keeping an eye on the Medicines Act — the RPS raises its issues and concerns
【24h】

Keeping an eye on the Medicines Act — the RPS raises its issues and concerns

机译:密切关注《药品法》-RPS提出了其问题和担忧

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

WE ALL know the Medicines Act 1968. It is our constant companion throughout our professional lives and we probably know it better than any other piece of legislation. However, it has got into a bit of a mess over the years. The Medicines and Healthcare products Regulatory Agency has been leading on a review of the current Medicines Act 1968 and intends to publish a formal consultation in autumn this year on the draft consolidated legislation, followed by a new Act in 2012.
机译:我们都知道《 1968年药品法》。它是我们职业生涯中始终如一的伴侣,我们可能比其他任何法规都更了解它。然而,多年来,它变得一团糟。药品和保健产品监管局一直在领导对现行的1968年药品法进行审查,并打算在今年秋天发布有关合并法规草案的正式咨询,随后在2012年发布新法案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号